Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

Clinical trial NCT05316701 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05316701
Sponsor: Orca Biosystems, Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Myeloid Leukemia Acute Lymphoid Leukemia Mixed Phenotype Acute Leukemia Undifferentiated Leukemia Myelodysplastic Syndrome Acute Leukemia Therapy-Related Myelodysplastic Syndrome

Start date: 2022-06-21
Primary completion: 2024-07-15
Enrollment: 187

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.